2-(Trifluoromethyl)benzaldehyde

We are 2-(Trifluoromethyl)benzaldehyde CAS:447-61-0 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:2-(Trifluoromethyl)benzaldehyde
CAS.NO:447-61-0
Synonyms:2-(Trifluoromethyl)benzaldehyde
A,A,A-TRIFLUORO-O-TOLUALDEHYDE
o-trifluoromethyl-benzaldehyde
2-(Trifluoromthyl)benzaldehyde
Molecular Formula:C8H5F3O
Molecular Weight:174.12000
 
Physical and Chemical Properties:
Density:1.32
Melting point:-40ºC
Boiling point:70-71ºC
Flash point:142°F
Index of Refraction:1.466
 
Specification:
Appearance:Colorless clear liquid
Assay:≥98.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Organic synthesis intermediate

2-(Trifluoromethyl)benzaldehyde


Related News: The outlook for a cure is clouded with theoretical uncertainties and high-profile failures. Pharmaceutical giants including Johnson & Johnson, Merck and Pfizer have ditched their projects on unsatisfactory data.2-(4'-Chloro[1,1'-biphenyl]-3-yl)-4,6-diphenyl-1,3,5-triazine The outlook for a cure is clouded with theoretical uncertainties and high-profile failures. Pharmaceutical giants including Johnson & Johnson, Merck and Pfizer have ditched their projects on unsatisfactory data.99-15-0 For example, an active ingredient to relieve pain is included in a painkiller.25660-71-3 INSPIRE is a global, multi-center, randomized, controlled study to assess the efficacy and safety of IV rigosertib in higher-risk MDS (HR-MDS) patients who had progressed on, failed to respond to, or relapsed after previous treatment with a hypomethylating agent (HMA) within nine cycles over the course of one year after initiation of HMA treatment.INSPIRE is a global, multi-center, randomized, controlled study to assess the efficacy and safety of IV rigosertib in higher-risk MDS (HR-MDS) patients who had progressed on, failed to respond to, or relapsed after previous treatment with a hypomethylating agent (HMA) within nine cycles over the course of one year after initiation of HMA treatment.

Related Products
Product Name
1,7-dichloro-4-methoxy-isoquinoline View Details
chlorotrimethylsilane View Details
2-Formylbenzenesulfonic Acid Sodium Salt View Details
Linaclotide manufacturer 3,5-Diiodosalicylic acid manufacturer 1-Hydroxyethylethoxypiperazine manufacturer cytosine manufacturer 2,3-Difluoro-4-methoxybenzonitrile manufacturer